Pim1 Serine/Threonine Kinase Regulates the Number and Functions of Murine Hematopoietic Stem Cells

The genes and pathways that govern the functions and expansion of hematopoietic stem cells (HSC) are not completely understood. In this study, we investigated the roles of serine/threonine Pim kinases in hematopoiesis in mice. We generated PIM1 transgenic mice (Pim1‐Tx) overexpressing human PIM1 driven by vav hematopoietic promoter/regulatory elements. Compared to wild‐type littermates, Pim1‐Tx mice showed enhanced hematopoiesis as demonstrated by increased numbers of Lin−Sca‐1 +c‐Kit + (LSK) hematopoietic stem/progenitor cells and cobblestone area forming cells, higher BrdU incorporation in long‐term HSC population, and a better ability to reconstitute lethally irradiated mice. We then extended our study using Pim1−/−, Pim2−/−, Pim3−/− single knockout (KO) mice. HSCs from Pim1−/− KO mice showed impaired long‐term hematopoietic repopulating capacity in secondary and competitive transplantations. Interestingly, these defects were not observed in HSCs from Pim2−/− or Pim3−/− KO mice. Limiting dilution competitive transplantation assay estimated that the frequency of LSKCD34− HSCs was reduced by approximately 28‐fold in Pim1−/− KO mice compared to wild‐type littermates. Mechanistic studies demonstrated an important role of Pim1 kinase in regulating HSC cell proliferation and survival. Finally, our polymerase chain reaction (PCR) array and confirmatory real‐time PCR (RT‐PCR) studies identified several genes including Lef‐1, Pax5, and Gata1 in HSCs that were affected by Pim1 deletion. Our data provide the first direct evidence for the important role of Pim1 kinase in the regulation of HSCs. Our study also dissects out the relative role of individual Pim kinase in HSC functions and regulation. STEM Cells 2013;31:1202–1212

[1]  Yubin Kang,et al.  Using quantitative real-time PCR to determine donor cell engraftment in a competitive murine bone marrow transplantation model. , 2013, Journal of visualized experiments : JoVE.

[2]  Masayuki Yamamoto,et al.  Contribution of GATA1 dysfunction to multi‐step leukemogenesis , 2012, Cancer science.

[3]  S. Nilsson,et al.  Bone, microenvironment and hematopoiesis , 2012, Current opinion in hematology.

[4]  F. Giles,et al.  The PIM kinases in hematological cancers , 2012, Expert review of hematology.

[5]  A. Kraft,et al.  The Pim protein kinases regulate energy metabolism and cell growth , 2010, Proceedings of the National Academy of Sciences.

[6]  Kwok-Kin Wong,et al.  Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. , 2010, The Journal of clinical investigation.

[7]  Jeffrey K. Mito,et al.  Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model , 2010, PloS one.

[8]  Stefan Knapp,et al.  PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers , 2010, Haematologica.

[9]  J. Chi,et al.  Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells , 2010, Nature Medicine.

[10]  W. Matsui,et al.  Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. , 2010, Blood.

[11]  Lijian Shao,et al.  Slug deficiency enhances self-renewal of hematopoietic stem cells during hematopoietic regeneration. , 2010, Blood.

[12]  Ying-Wei Lin,et al.  A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. , 2010, Blood.

[13]  Mark A Sussman,et al.  Enhancement of Myocardial Regeneration Through Genetic Engineering of Cardiac Progenitor Cells Expressing Pim-1 Kinase , 2009, Circulation.

[14]  Stefan Knapp,et al.  Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration , 2009, The Journal of experimental medicine.

[15]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[16]  Lisa S. Chen,et al.  Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells. , 2008, Blood.

[17]  S. Salati,et al.  Signal control of hematopoietic stem cell fate: Wnt, Notch, and Hedgehog as the usual suspects , 2008, Current opinion in hematology.

[18]  T. Kitamura,et al.  Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene , 2008, International journal of hematology.

[19]  G. de Haan,et al.  In vitro assays for cobblestone area-forming cells, LTC-IC, and CFU-C. , 2008, Methods in molecular biology.

[20]  Marielle Afanassieff,et al.  Self‐Renewal of Murine Embryonic Stem Cells Is Supported by the Serine/Threonine Kinases Pim‐1 and Pim‐3 , 2007, Stem cells.

[21]  D. Largaespada,et al.  Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells. , 2007, Experimental hematology.

[22]  E. Passegué,et al.  Evidence that the Pim1 kinase gene is a direct target of HOXA9. , 2007, Blood.

[23]  P. Quesenberry,et al.  Murine allogeneic in vivo stem cell homing , , 2007, Journal of cellular physiology.

[24]  K. Tsuneyama,et al.  Proto‐oncogene, Pim‐3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad‐mediated apoptosis , 2007, Cancer science.

[25]  E. Passegué,et al.  Evidence that the Pim 1 kinase gene is a direct target of HOXA 9 , 2007 .

[26]  Hiroshi Ishikura,et al.  Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. , 2006, Cancer research.

[27]  B. Storer,et al.  Competing Interests: The authors , 2004 .

[28]  T. Möröy,et al.  The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C. , 2006, The international journal of biochemistry & cell biology.

[29]  J. Arthur,et al.  Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL , 2006, BMC Cell Biology.

[30]  A. Kraft,et al.  Pim Family Kinases Enhance Tumor Growth of Prostate Cancer Cells , 2005, Molecular Cancer Research.

[31]  S. E. Jacobsen,et al.  Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. , 2005, Blood.

[32]  P. Koskinen,et al.  Pim‐1 kinase promotes inactivation of the pro‐apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site , 2004, FEBS letters.

[33]  Jos Jonkers,et al.  Mice Deficient for All PIM Kinases Display Reduced Body Size and Impaired Responses to Hematopoietic Growth Factors , 2004, Molecular and Cellular Biology.

[34]  Anton Berns,et al.  High-throughput retroviral tagging to identify components of specific signaling pathways in cancer , 2002, Nature Genetics.

[35]  T. Kitamura,et al.  Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation. , 2002, Experimental hematology.

[36]  M. Schebesta,et al.  Transcriptional control of B-cell development. , 2002, Current opinion in immunology.

[37]  J. Kolls,et al.  Chimerism analysis in sex-mismatched murine transplantation using quantitative real-time PCR. , 2002, BioTechniques.

[38]  Z. Wang,et al.  Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. , 2001, Journal of veterinary science.

[39]  S. Jacobsen,et al.  Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. , 2001, Immunity.

[40]  D. Wojchowski,et al.  Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death , 2000, Oncogene.

[41]  R Grosschedl,et al.  Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. , 2000, Immunity.

[42]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Visvader,et al.  Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. , 1998, Blood.

[44]  A. Kraft,et al.  Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells. , 1997, Cancer research.

[45]  A. Berns,et al.  Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc , 1997, Oncogene.

[46]  P. Laird,et al.  Pim-1 levels determine the size of early B lymphoid compartments in bone marrow , 1993, The Journal of experimental medicine.

[47]  P. Laird,et al.  In vivo analysis of Pim-1 deficiency. , 1993, Nucleic acids research.

[48]  F. Sigaux,et al.  The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Berns,et al.  Evidence for the involvement of pim‐2, a new common proviral insertion site, in progression of lymphomas. , 1989, The EMBO journal.

[50]  A. Berns,et al.  Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors , 1989, Cell.

[51]  Wim Quint,et al.  Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region , 1984, Cell.